• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Hypodermic Needle Market

    ID: MRFR/HC/39097-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    Hypodermic Needle Market Research Report By Needle Diameter (26 Gauge, 27 Gauge, 28 Gauge, 30 Gauge, 31 Gauge), By Needle Length (1/2 inch, 5/8 inch, 1 inch, 1 1/2 inch, 2 inch), By Needle Point Type (Sharp Point, Blunt Point, Pencil Point, Reverse Bevel Point, Luer Slip Point), By Needle Hub Type (Luer Lock Hub, Slip-On Hub, Threaded Hub, Eccentric Hub), By Needle Material (Stainless Steel, Plastic, Glass, Ceramic) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Hypodermic Needle Market Infographic
    Purchase Options

    Hypodermic Needle Market Summary

    The Global Hypodermic Needle Market is projected to grow from 4.92 USD Billion in 2024 to 7.19 USD Billion by 2032.

    Key Market Trends & Highlights

    Hypodermic Needle Key Trends and Highlights

    • The market is expected to witness a compound annual growth rate (CAGR) of 3.51% from 2025 to 2032.
    • By 2035, the market valuation is anticipated to reach 7.19 USD Billion, indicating robust growth.
    • In 2024, the market is valued at 4.92 USD Billion, reflecting a strong foundation for future expansion.
    • Growing adoption of hypodermic needles due to increasing healthcare needs is a major market driver.

    Market Size & Forecast

    2024 Market Size 4.92 (USD Billion)
    2035 Market Size 7.19 (USD Billion)
    CAGR (2025-2035) 3.51%

    Major Players

    Terumo Corporation, Becton, Dickinson and Company, Medtronic plc, AmerisourceBergen Corporation, Nipro Corporation, Boston Scientific Corporation, Fresenius Kabi AG, Owens Minor, Inc., Henry Schein, Inc., Smiths Group plc, Braun Melsungen AG, Cardinal Health, Baxter International Inc., McKesson Corporation

    Hypodermic Needle Market Trends

    The Hypodermic Needle Market appears to be expanding quickly owing to robust technological advancements and the rising demand for chronic illness management solutions. The increasing prevalence of the elderly population, as well as the global penetration of emerging markets, all play an essential role in bringing about transformation. New advancements in depression therapy, such as the discovery of new chronic pain medical treatments, as well as increased use of home care devices and geriatric patients, have all contributed to the growth of the market.

    It also extended opportunities for the development of improved safety-enhanced needles and improved needle coatings and material and also focused on integrating smart technologies For tracking the needles. Trends such as the use of single-use needles focus on ultra-fine needles and needle-free injection systems for enhanced patient comfort support, minimizing infection risks and needle trauma. These innovations aim to augment patient safety, lessen discomfort during procedures, and improve healthcare result that boosts the growth of the hypodermic needle market in the ongoing years.

    The ongoing advancements in hypodermic needle technology, particularly in safety and precision, appear to be reshaping the landscape of medical practices globally, enhancing patient care and reducing the risk of needlestick injuries.

    U.S. Food and Drug Administration (FDA)

    Hypodermic Needle Market Drivers

    Market Growth Projections

    The Global Hypodermic Needle Market Industry is poised for substantial growth, with projections indicating a market size of 4.92 USD Billion in 2024 and an anticipated increase to 7.19 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate of 3.51% from 2025 to 2035. Such figures highlight the increasing reliance on hypodermic needles across various healthcare applications, including vaccinations, chronic disease management, and emergency care. The market's expansion reflects broader trends in healthcare, emphasizing the need for efficient and safe medical devices to meet the demands of a growing and aging population.

    Technological Advancements

    Technological innovations in hypodermic needle design and manufacturing are propelling the Global Hypodermic Needle Market Industry forward. The introduction of safety-engineered needles, which reduce the risk of needlestick injuries, is particularly noteworthy. These advancements not only enhance patient safety but also comply with stringent regulatory standards. As healthcare providers increasingly prioritize safety, the adoption of these innovative products is likely to grow. This shift may contribute to the market's expansion, with projections indicating a rise to 7.19 USD Billion by 2035. The integration of smart technologies, such as needle tracking systems, further underscores the potential for growth in this sector.

    Increase in Chronic Diseases

    The rising prevalence of chronic diseases globally is a significant factor influencing the Global Hypodermic Needle Market Industry. Conditions such as diabetes, cancer, and cardiovascular diseases require regular medical interventions, including injections and blood sampling. As the global population ages and lifestyle-related health issues escalate, the demand for hypodermic needles is expected to increase. This trend is particularly evident in developed nations where healthcare systems are adapting to manage chronic conditions more effectively. The anticipated growth in this market segment aligns with the overall market forecast, which suggests a compound annual growth rate of 3.51% from 2025 to 2035.

    Rising Demand for Vaccination

    The increasing global emphasis on vaccination programs is a primary driver of the Global Hypodermic Needle Market Industry. With governments and health organizations advocating for immunization against various diseases, the demand for hypodermic needles is expected to rise significantly. In 2024, the market is projected to reach 4.92 USD Billion, reflecting the urgency to equip healthcare facilities with adequate supplies. This trend is likely to continue as vaccination campaigns expand, particularly in developing regions where access to healthcare is improving. The focus on preventive healthcare is anticipated to sustain growth in the hypodermic needle sector.

    Expansion of Healthcare Infrastructure

    The ongoing expansion of healthcare infrastructure in emerging economies is driving the Global Hypodermic Needle Market Industry. As countries invest in healthcare facilities, the need for medical supplies, including hypodermic needles, is growing. Governments are increasingly recognizing the importance of accessible healthcare, leading to the establishment of new hospitals and clinics. This trend is particularly pronounced in regions such as Asia-Pacific and Latin America, where healthcare access is improving. The resulting increase in demand for hypodermic needles is expected to contribute to the market's growth trajectory, supporting the overall industry expansion in the coming years.

    Regulatory Compliance and Safety Standards

    The stringent regulatory environment surrounding medical devices, including hypodermic needles, is a crucial driver of the Global Hypodermic Needle Market Industry. Compliance with safety standards is paramount for manufacturers, as it ensures the protection of both healthcare providers and patients. Regulatory bodies are continuously updating guidelines to enhance safety and efficacy, which influences product development and innovation. As manufacturers adapt to these regulations, there is likely to be a shift towards safer, more efficient hypodermic needles. This focus on compliance not only fosters consumer trust but also positions the industry for sustained growth in the future.

    Market Segment Insights

    Hypodermic Needle Market Needle Diameter Insights  

    The Hypodermic Needle Market segmentation by Needle Diameter is anticipated to showcase considerable growth potential in the years to come, driven by factors such as the increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and technological advancements in needle design. The market is segmented into various needle diameters, including 26 Gauge, 27 Gauge, 28 Gauge, 30 Gauge, and 31 Gauge, each catering to specific medical applications.

    Among these, 26 Gauge needles are widely used for intramuscular injections, blood collection, and subcutaneous injections due to their larger diameter and ability to accommodate higher flow rates.27 Gauge needles, on the other hand, offer a balance between flow rate and patient comfort, making them suitable for subcutaneous injections, intravenous infusions, and blood draws. 28 Gauge needles are commonly employed for intradermal injections, while 30 Gauge needles are preferred for delicate procedures such as insulin injections and vaccinations. 31 Gauge needles, with their ultra-fine diameter, are ideal for applications requiring minimal tissue trauma, such as intradermal testing and cosmetic procedures.

    The Hypodermic Needle Market revenue for 27 Gauge needles is projected to reach $750 million by 2024, capturing a significant share of the overall market. The growing demand for minimally invasive procedures, coupled with the increasing prevalence of chronic diseases, is expected to drive the growth of this segment. Furthermore, technological advancements, such as the development of atraumatic needles designed to minimize pain and tissue damage, are anticipated to fuel market expansion in the coming years.

    Overall, the Needle Diameter segment of the Hypodermic Needle Market presents immense opportunities for growth, with each diameter catering to specific medical applications and offering unique advantages.The increasing demand for minimally invasive procedures, coupled with technological advancements and the rising prevalence of chronic diseases, is expected to propel the growth of this market segment in the years to come.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Hypodermic Needle Market Needle Length Insights  

    The needle length segment plays a significant role in the Hypodermic Needle Market. Different needle lengths cater to specific medical applications and patient needs. Among the mentioned needle lengths, 1/2 inch and 5/8 inch are commonly used for intradermal and subcutaneous injections, respectively. These shorter needles are preferred for vaccinations, allergy testing, and insulin administration. In contrast, longer needles like 1 inch, 1 1/2 inch, and 2 inch are utilized for intramuscular and intravenous injections.

    These needles provide deeper penetration, reaching muscles or veins for medication delivery or blood collection.The Hypodermic Needle Market data indicates that in 2024, the 1/2 inch segment held a significant market share, followed by 5/8 inch. The growth in this segment can be attributed to the increasing prevalence of chronic diseases and the rising demand for self-injection therapies. Furthermore, the market segmentation and insights highlight the importance of needle length in ensuring patient safety and comfort during medical procedures, driving the continued growth of this segment in the Hypodermic Needle Market industry.

    Hypodermic Needle Market Needle Point Type Insights  

    The Hypodermic Needle Market segmentation by Needle Point Type comprises Sharp Point, Blunt Point, Pencil Point, Reverse Bevel Point, and Luer Slip Point. In 2023, the Sharp Point segment held the largest market share of 45%, owing to its wide usage in injections and blood collection.

    The Blunt Point segment is projected to exhibit the highest CAGR of 4.2% during the forecast period, driven by its increasing adoption in applications such as insulin delivery and vaccinations. The Pencil Point segment accounted for a market share of 22% in 2023 and is expected to witness steady growth due to its precision in delivering medications and fluids.The Reverse Bevel Point segment held a share of 18% in 2023 and is anticipated to maintain its position in the market.

    The Luer Slip Point segment accounted for a share of 15% in 2023 and is projected to experience moderate growth over the forecast period.

    Hypodermic Needle Market Needle Hub Type Insights  

    Needle Hub Type segments the Hypodermic Needle Market into Luer Lock Hub, Slip-On Hub, Threaded Hub, and Eccentric Hub. Among these, the Luer Lock Hub segment held the largest market share in 2023 and is projected to maintain its dominance throughout the forecast period.

    The Luer Lock Hub type provides a secure and leak-proof connection between the needle and syringe, making it the preferred choice for critical applications such as drug delivery and blood collection. The Slip-On Hub segment is anticipated to witness steady growth owing to its ease of use and affordability.The Threaded Hub and Eccentric Hub segments are expected to account for a smaller share of the market but are projected to grow at a moderate pace due to their specific applications in specialized medical procedures.

    Hypodermic Needle Market Needle Material Insights  

    The Hypodermic Needle Market segmentation by Needle Material comprises Stainless Steel, Plastic, Glass, and Ceramic. Stainless Steel held the largest market share in 2023, owing to its durability, cost-effectiveness, and resistance to corrosion. Plastic needles are gaining popularity due to their low cost, disposability, and transparency, which allow for easy visualization of the injection process. Glass needles offer high precision and chemical inertness, making them suitable for specialized applications. Ceramic needles are emerging as a promising alternative due to their high strength, biocompatibility, and resistance to wear and tear.

    Get more detailed insights about Hypodermic Needle Market

    Regional Insights

    The Hypodermic Needle Market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. North America is the largest regional market for hypodermic needles, followed by Europe and Asia-Pacific. The growth of the North American market is attributed to the increasing prevalence of chronic diseases, the rising demand for minimally invasive procedures, and the presence of major market players.

    The European market is also expected to grow significantly due to the increasing adoption of advanced healthcare technologies and the growing demand for home healthcare services.The Asia-Pacific market is expected to witness the fastest growth over the forecast period due to the rising healthcare expenditure, the increasing prevalence of infectious diseases, and the growing demand for affordable healthcare solutions. South America, the Middle East, and Africa are expected to experience moderate growth due to the limited healthcare infrastructure and the low penetration of advanced medical technologies.

    Hypodermic Needle Market Regional Insights  

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    Major players in the Hypodermic Needle Market industry are constantly striving to develop new and innovative products to meet the evolving needs of the market. Leading Hypodermic Needle Market players are investing heavily in research and development to improve the safety, efficacy, and convenience of their products. The Hypodermic Needle Market industry is characterized by intense competition, with a number of leading players vying for market share. The competitive landscape is expected to remain fragmented over the forecast period, with no single player holding a dominant position.Terumo Corporation is a leading global provider of medical devices, including hypodermic needles.

    The company has a strong track record of innovation and is committed to providing high-quality products that meet the needs of its customers. Terumo Corporation has a wide range of hypodermic needles available, including needles for a variety of applications, such as injections, blood collection, and IV therapy.

    The company's needles are known for their sharpness, durability, and safety. Terumo Corporation Hypodermic Needle Market development efforts are focused on improving the safety and efficacy of its needles, as well as developing new needles for emerging applications.Becton, Dickinson and Company (BD) is another leading player in the Hypodermic Needle Market industry.

    BD is a global medical technology company that produces a wide range of products, including hypodermic needles. The company is committed to providing innovative and high-quality products that meet the needs of its customers. BD's hypodermic needles are available in a variety of sizes and gauges and are designed to meet the specific needs of each application. The company's needles are known for their sharpness, durability, and safety. BD is constantly investing in research and development to improve the safety and efficacy of its needles, as well as developing new needles for emerging applications.

    Key Companies in the Hypodermic Needle Market market include

    Industry Developments

    • Q1 2024: BD Launches UltraSafe Plus™ 2.25 mL Passive Needle Guard for Pre-Filled Syringes BD announced the launch of its UltraSafe Plus™ 2.25 mL Passive Needle Guard, designed to enhance safety for healthcare workers and patients during drug administration with pre-filled syringes.
    • Q2 2024: Terumo Opens New Manufacturing Facility in Vietnam to Expand Hypodermic Needle Production Terumo Corporation inaugurated a new manufacturing plant in Vietnam to increase its production capacity for hypodermic needles, aiming to meet rising global demand.
    • Q2 2024: Owen Mumford Launches Unifine® SafeControl® Pen Needles in Europe Owen Mumford introduced its Unifine® SafeControl® pen needles in several European markets, targeting improved safety and ease of use for insulin-dependent patients.
    • Q2 2024: Novo Nordisk Announces Partnership with Ypsomed for Next-Generation Pen Needles Novo Nordisk entered a partnership with Ypsomed to co-develop next-generation pen needles, focusing on enhanced safety features and compatibility with insulin delivery devices.
    • Q3 2024: HTL-STREFA Receives CE Mark Approval for Safety Hypodermic Needle HTL-STREFA announced it has received CE Mark approval for its new safety hypodermic needle, enabling commercialization in the European Union.
    • Q3 2024: Cardinal Health Expands Hypodermic Needle Portfolio with Launch of Safety-Engineered Products Cardinal Health launched a new line of safety-engineered hypodermic needles designed to reduce the risk of needlestick injuries in clinical settings.
    • Q3 2024: B. Braun Opens New R&D Center Focused on Hypodermic Needle Innovation B. Braun inaugurated a research and development center dedicated to advancing hypodermic needle technology, with a focus on safety and patient comfort.
    • Q4 2024: DeRoyal Announces Strategic Partnership with U.S. Hospital Network for Hypodermic Needle Supply DeRoyal entered a strategic partnership with a major U.S. hospital network to supply hypodermic needles, aiming to improve supply chain reliability and product quality.
    • Q4 2024: BD Secures Large-Scale Contract with UK NHS for Safety Hypodermic Needles BD won a significant contract to supply safety hypodermic needles to the UK National Health Service, supporting national efforts to reduce needlestick injuries.
    • Q1 2025: Artsana S.p.A. Launches Eco-Friendly Hypodermic Needle Line Artsana S.p.A. introduced a new line of eco-friendly hypodermic needles, featuring recyclable materials and reduced environmental impact.
    • Q2 2025: Trividia Health Announces FDA Clearance for New Hypodermic Needle Product Trividia Health received FDA clearance for its latest hypodermic needle product, enabling U.S. market entry and expanding its medical device portfolio.
    • Q2 2025: Perrigo Company plc Appoints New CEO to Drive Growth in Medical Devices Segment Perrigo Company plc announced the appointment of a new CEO, with a mandate to accelerate growth in its medical devices segment, including hypodermic needles.

    Future Outlook

    Hypodermic Needle Market Future Outlook

    The Global Hypodermic Needle Market is projected to grow at a 3.51% CAGR from 2024 to 2032, driven by advancements in medical technology and increasing healthcare demands.

    New opportunities lie in:

    • Develop smart hypodermic needles with integrated sensors for enhanced patient monitoring.
    • Expand production capabilities in emerging markets to meet rising demand.
    • Invest in eco-friendly materials for needle production to attract environmentally conscious consumers.

    By 2035, the market is expected to exhibit robust growth, reflecting evolving healthcare needs and technological advancements.

    Market Segmentation

    Hypodermic Needle Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia-Pacific
    • Middle East and Africa

    Hypodermic Needle Market Needle Length Outlook

    • 1/2 inch
    • 5/8 inch
    • 1 inch
    • 1 1/2 inch
    • 2 inch

    Hypodermic Needle Market Needle Diameter Outlook

    • 26 Gauge
    • 27 Gauge
    • 28 Gauge
    • 30 Gauge
    • 31 Gauge

    Hypodermic Needle Market Needle Hub Type Outlook

    • Luer Lock Hub
    • Slip-On Hub
    • Threaded Hub
    • Eccentric Hub

    Hypodermic Needle Market Needle Material Outlook

    • Stainless Steel
    • Plastic
    • Glass
    • Ceramic

    Hypodermic Needle Market Needle Point Type Outlook

    • Sharp Point
    • Blunt Point
    • Pencil Point
    • Reverse Bevel Point
    • Luer Slip Point

    Report Scope

    Report Attribute/Metric Details
    Market Size 2022 4.65(USD Billion)
    Market Size 2023 4.8(USD Billion)
    Market Size 2032 6.5(USD Billion)
    Compound Annual Growth Rate (CAGR) 3.42% (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2018-2022
    Market Forecast Units USD Billion
    Key Companies Profiled Medtronic plc, Terumo Corporation, AmerisourceBergen Corporation, Nipro Corporation, Boston Scientific Corporation, Fresenius Kabi AG, Owens  Minor, Inc., Henry Schein, Inc., Becton, Dickinson and Company, Smiths Group plc, Braun Melsungen AG, Cardinal Health, Baxter International Inc., McKesson Corporation
    Segments Covered Needle Diameter, Needle Length, Needle Point Type, Needle Hub Type, Needle Material, Regional
    Key Market Opportunities Increasing prevalence of chronic diseases Adoption of safety devices Technological advancements Growing geriatric population Expanding healthcare infrastructure
    Key Market Dynamics Growing preference for minimally invasive procedures Technological advancements Increasing prevalence of chronic diseases Government initiatives for healthcare infrastructure development Rising demand for safety and efficiency in healthcare settings
    Countries Covered North America, Europe, APAC, South America, MEA

    FAQs

    What is the projected market size of the Hypodermic Needle Market in 2023?

    The Hypodermic Needle Market is expected to be valued at approximately 4.8 billion USD in 2023.

    What is the projected market size of the Hypodermic Needle Market in 2032?

    The Hypodermic Needle Market is projected to reach a valuation of around 6.5 billion USD by 2032.

    What is the estimated CAGR of the Hypodermic Needle Market between 2024 and 2032?

    The Hypodermic Needle Market is anticipated to Register a CAGR of approximately 3.42% during the forecast period from 2024 to 2032.

    Which region is expected to dominate the Hypodermic Needle Market during the forecast period?

    North America is projected to remain the dominant region in the Hypodermic Needle Market throughout the forecast period.

    What are the major factors driving the growth of the Hypodermic Needle Market?

    The rising prevalence of chronic diseases, increasing demand for minimally invasive procedures, and technological advancements are key factors propelling market growth.

    What are the primary applications of hypodermic needles?

    Hypodermic needles are primarily used for injections, blood collection, and other medical procedures.

    Who are the key competitors in the Hypodermic Needle Market?

    Major players in the Hypodermic Needle Market include Terumo Medical Corporation, Becton, Dickinson and Company, and Smiths Medical.

    What are the emerging trends in the Hypodermic Needle Market?

    Advancements in needle design, such as safety needles and pen needles, are notable trends in the market.

    What are the challenges faced by the Hypodermic Needle Market?

    Fluctuating raw material prices and stringent regulatory requirements pose challenges to market growth.

    What is the expected impact of technological advancements on the Hypodermic Needle Market?

    Technological advancements, such as automated needle production and smart needles, are anticipated to drive market growth.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials